PHARMACOKINETICS OF HUMAN LEUKOCYTE INTERFERON

被引:37
作者
CANTELL, K [1 ]
PYHALA, L [1 ]
机构
[1] CENT PUBL HLTH LAB,DEPT VIROL,HELSINKI 28,FINLAND
关键词
D O I
10.1093/infdis/133.Supplement_2.A6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A6 / A12
页数:7
相关论文
共 11 条
[1]   CIRCULATING INTERFERON IN RABBITS AFTER ADMINISTRATION OF HUMAN INTERFERON BY DIFFERENT ROUTES [J].
CANTELL, K ;
PYHALA, L .
JOURNAL OF GENERAL VIROLOGY, 1973, 20 (JUL) :97-104
[2]  
CANTELL K, 1974, 3 TISS CULT ASS MON, P35
[3]  
CANTELL K, 1974, J GEN VIROL, V22, P453
[4]  
EMODI G, 1975, J NATL CANCER I, V54, P1045
[5]  
FORD WL, 1973, HDB EXPT IMMUNOLOGY, V2
[6]  
HO M, 1967, 1 INT C VACC AG VIR, P632
[7]   ADMINISTRATION OF HUMAN LEUKOCYTE INTERFERON IN HERPES-ZOSTER .1. SAFETY, CIRCULATING ANTIVIRAL ACTIVITY, AND HOST RESPONSES TO INFECTION [J].
JORDAN, GW ;
FRIED, RP ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (01) :56-62
[8]  
MOGENSEN KE, 1974, ACTA PATH MICRO IM B, VB 82, P305
[9]  
PYHALA L, 1974, P SOC EXP BIOL MED, V146, P394
[10]  
SKREKO F, 1973, P SOC EXP BIOL MED, V142, P946